Rubiadin 1-methyl etherCAS# 7460-43-7 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 7460-43-7 | SDF | Download SDF |
| PubChem ID | 96191 | Appearance | Yellow powder |
| Formula | C16H12O4 | M.Wt | 268.3 |
| Type of Compound | Anthraquinones | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 3-hydroxy-1-methoxy-2-methylanthracene-9,10-dione | ||
| SMILES | CC1=C(C=C2C(=C1OC)C(=O)C3=CC=CC=C3C2=O)O | ||
| Standard InChIKey | NTBUBTCXACOEEC-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C16H12O4/c1-8-12(17)7-11-13(16(8)20-2)15(19)10-6-4-3-5-9(10)14(11)18/h3-7,17H,1-2H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Rubiadin-1-methyl ether probed as Type I photosensitizers. Rubiadin 1-methyl ether decreases the number of parasites (schizonts) in a dose-dependent manner, and 100% of inhibition was obtained with 30 to 40 micrograms. Rubiadin-1-methyl ether shows strong enhancing activity for adipocyte differentiation, it could be beneficial in the treatment of diabetes. Rubiadin-1-methyl ether has therapeutic potential against osteoporosis, it can promote osteoblast proliferation and inhibit osteoclast TRAP activity and bone resorption, and the inhibitory effects on osteoclastic bone, antiosteoporotic activity of M. officinalis . |
| Targets | Antifection |
| In vitro | Anthraquinones from Morinda officinalis roots enhance adipocyte differentiation in 3T3-L1 cells.[Pubmed: 22008000]Nat Prod Res. 2012;26(18):1750-4.To search for anti-diabetic and insulin-sensitising natural products, the effect on adipocyte differentiation was investigated by assessing fat accumulation in 3T3-L1 preadipocytes using Oil Red O staining. Effects of three compounds extracted from Morinda lucida on Plasmodium falciparum.[Pubmed: 1484892]Planta Med. 1992 Dec;58(6):533-4.The effects of three compounds, digitolutein (1), Rubiadin 1-methyl ether (2) and damnacanthal (3) extracted from the stem bark and the roots of Morinda lucida Benth. on the growth of Plasmodium falciparum in vitro were investigated. Natural anthraquinones probed as Type I and Type II photosensitizers: singlet oxygen and superoxide anion production.[Pubmed: 15629252 ]J Photochem Photobiol B. 2005 Jan 14;78(1):77-83.The photosensitizing properties of six anthraquinones (AQs): soranjidiol (1), soranjidiol-1-methyl ether (2), rubiadin (3), rubiadin-1-methyl ether (4), damnacanthal (5) and damnacanthol (6), isolated from leaves and stems of Heterophyllaea pustulata Hook. f. (Rubiaceae) were studied.
|
| Cell Research | Antiosteoporotic activity of anthraquinones from Morinda officinalis on osteoblasts and osteoclasts.[Pubmed: 19169204]Molecules. 2009 Jan 23;14(1):573-83.Bioactivity-guided fractionation led to the successful isolation of antiosteoporotic components, i.e. physicion (1), rubiadin-1-methyl ether (2), 2-hydroxy-1-methoxy- anthraquinone (3), 1,2-dihydroxy-3-methylanthraquinone (4), 1,3,8-trihydroxy-2-methoxy- anthraquinone (5), 2-hydroxymethyl-3-hydroxyanthraquinone (6), 2-methoxyanthraquinone (7) and scopoletin (8) from an ethanolic extract of the roots of Morinda officinalis. |
Rubiadin 1-methyl ether Dilution Calculator
Rubiadin 1-methyl ether Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.7272 mL | 18.6359 mL | 37.2717 mL | 74.5434 mL | 93.1793 mL |
| 5 mM | 0.7454 mL | 3.7272 mL | 7.4543 mL | 14.9087 mL | 18.6359 mL |
| 10 mM | 0.3727 mL | 1.8636 mL | 3.7272 mL | 7.4543 mL | 9.3179 mL |
| 50 mM | 0.0745 mL | 0.3727 mL | 0.7454 mL | 1.4909 mL | 1.8636 mL |
| 100 mM | 0.0373 mL | 0.1864 mL | 0.3727 mL | 0.7454 mL | 0.9318 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- D-64131
Catalog No.:BCC1510
CAS No.:74588-78-6
- Isomedicarpin
Catalog No.:BCN4297
CAS No.:74560-05-7
- Cristacarpin
Catalog No.:BCN3935
CAS No.:74515-47-2
- UBP 302
Catalog No.:BCC7256
CAS No.:745055-91-8
- UBP 296
Catalog No.:BCC7255
CAS No.:745055-86-1
- Ivachtin
Catalog No.:BCC2357
CAS No.:745046-84-8
- MMAF
Catalog No.:BCC5144
CAS No.:745017-94-1
- Alprostadil
Catalog No.:BCC4963
CAS No.:745-65-3
- Casegravol
Catalog No.:BCN4591
CAS No.:74474-76-3
- Potassium Chloride
Catalog No.:BCC7581
CAS No.:7447-40-7
- Sauvagine
Catalog No.:BCC5792
CAS No.:74434-59-6
- Symlandine
Catalog No.:BCN1974
CAS No.:74410-74-5
- Tetrahydrocoptisine
Catalog No.:BCN2558
CAS No.:7461-02-1
- Tylosin tartrate
Catalog No.:BCC4875
CAS No.:74610-55-2
- ent-3Beta-Angeloyloxykaur-16-en-19-oic acid
Catalog No.:BCN1365
CAS No.:74635-61-3
- 11-Hydroxydrim-7-en-6-one
Catalog No.:BCN7770
CAS No.:74635-87-3
- Liquiritin Apioside
Catalog No.:BCC8334
CAS No.:74639-14-8
- 1,3,9-Trimethyluric acid
Catalog No.:BCN7393
CAS No.:7464-93-9
- Nuclear yellow
Catalog No.:BCC1810
CAS No.:74681-68-8
- 3-Methoxy-4,5-methylenedioxycinnamaldehyde
Catalog No.:BCN1364
CAS No.:74683-19-5
- 4-hydroxy-1-methoxycarbonyl-beta-carboline
Catalog No.:BCN7909
CAS No.:74690-72-5
- 1-Methoxycarbonyl-beta-carboline-N-oxide
Catalog No.:BCN8205
CAS No.:74690-74-7
- Vibsanin C
Catalog No.:BCN4590
CAS No.:74690-89-4
- Hydroxychloroquine Sulfate
Catalog No.:BCC5560
CAS No.:747-36-4
Effects of three compounds extracted from Morinda lucida on Plasmodium falciparum.[Pubmed:1484892]
Planta Med. 1992 Dec;58(6):533-4.
The effects of three compounds, digitolutein (1), Rubiadin 1-methyl ether (2) and damnacanthal (3) extracted from the stem bark and the roots of Morinda lucida Benth. on the growth of Plasmodium falciparum in vitro were investigated. The number of parasites (schizonts) decreased significantly in a dose-dependent manner, and 100% of inhibition was obtained with 30 to 40 micrograms of each compound tested. The IC50 values were calculated.
Anthraquinones from Morinda officinalis roots enhance adipocyte differentiation in 3T3-L1 cells.[Pubmed:22008000]
Nat Prod Res. 2012;26(18):1750-4.
To search for anti-diabetic and insulin-sensitising natural products, the effect on adipocyte differentiation was investigated by assessing fat accumulation in 3T3-L1 preadipocytes using Oil Red O staining. Fractionation and separation of n-hexane and CHCl(3) fractions of Morinda officinalis (Rubiaceae) using several chromatographic methods led to the isolation of three anthraquinones, 1,2-dimethoxyanthraquinone (1), alizarin-2-methyl ether (2) and rubiadin-1-methyl ether (3). Among them, alizarin-2-methyl ether (2) showed the strongest enhancing activity, followed by rubiadin-1-methyl ether (3) and 1,2-dimethoxyanthraquinone (1). At a concentration of 100 microM, alizarin-2-methyl ether (2) enhanced adipocyte differentiation by up to 131% (compared to insulin-treated cells). Thus, these compounds could be beneficial in the treatment of diabetes.
Natural anthraquinones probed as Type I and Type II photosensitizers: singlet oxygen and superoxide anion production.[Pubmed:15629252]
J Photochem Photobiol B. 2005 Jan 14;78(1):77-83.
The photosensitizing properties of six anthraquinones (AQs): soranjidiol (1), soranjidiol-1-methyl ether (2), rubiadin (3), rubiadin-1-methyl ether (4), damnacanthal (5) and damnacanthol (6), isolated from leaves and stems of Heterophyllaea pustulata Hook. f. (Rubiaceae) were studied. By means of photobiological and photophysical methods in vitro, the type of photosensitization that these metabolites are capable of producing was determined. Whereas the photosensitized generation of superoxide anion radical (O(2)(-)) (Type I) was evaluated in leukocyte suspensions, singlet molecular oxygen ((1)O(2)) production (Type II) was examined in organic solution. In addition, the quantum yield of (1)O(2) (Phi) in chloroform was measured for those AQs that generate it. It was established that 4 behaves exclusively as a Type I photosensitizer. By contrast, the others AQs act by both types of mechanisms, among which 5 showed the largest Phi of (1)O(2).
Antiosteoporotic activity of anthraquinones from Morinda officinalis on osteoblasts and osteoclasts.[Pubmed:19169204]
Molecules. 2009 Jan 23;14(1):573-83.
Bioactivity-guided fractionation led to the successful isolation of antiosteoporotic components, i.e. physicion (1), rubiadin-1-methyl ether (2), 2-hydroxy-1-methoxy- anthraquinone (3), 1,2-dihydroxy-3-methylanthraquinone (4), 1,3,8-trihydroxy-2-methoxy- anthraquinone (5), 2-hydroxymethyl-3-hydroxyanthraquinone (6), 2-methoxyanthraquinone (7) and scopoletin (8) from an ethanolic extract of the roots of Morinda officinalis. Compounds 4-8 are isolated for the first time from M. officinalis. Among them, compounds 2 and 3 promoted osteoblast proliferation, while compounds 4, 5 increased osteoblast ALP activity. All of the isolated compounds inhibited osteoclast TRAP activity and bone resorption, and the inhibitory effects on osteoclastic bone resorption of compounds 1 and 5 were stronger than that of other compounds. Taken together, antiosteoporotic activity of M. officinalis and its anthraquinones suggest therapeutic potential against osteoporosis.
